瘤微环境中的免疫抑制场景
Wuyi Liu1, Huyue Zhou1, Wenjing Lai1
1Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, 83 Xinqiao Road, Shapingba, Chongqing, China.
Immunologic research
|May 1, 2024
概括
使用免疫检查点抑制剂 (ICI) 的癌症免疫疗法显示出有前途,但许多患者仍然没有反应. 本综述探讨了瘤微环境中的免疫抑制因素,以提高ICI治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 癌症免疫疗法,特别是免疫检查点抑制剂 (ICI),已经改变了患者的治疗结果.
- 然而,大量患者对目前的ICI治疗没有反应,凸显了未满足的临床需求.
- 瘤微环境在调节对抗癌症的免疫反应中起着至关重要的作用.
研究的目的:
- 总结最近对瘤微环境中的免疫抑制因素的研究和见解.
- 为提供瘤免疫抑制微环境的最新景观.
- 确定潜在的新策略来克服对癌症免疫疗法的抗性.
主要方法:
- 综合审查先进的研究和最新的科学文献.
- 深入分析免疫抑制因素及其机制.
- 综合关于瘤免疫抑制微环境的当前知识.
主要成果:
- 确定了导致治疗耐药性的关键免疫抑制因素.
- 详细介绍了免疫抑制瘤微环境中的细胞和分子组件的复杂相互作用.
- 突出了调节瘤微环境的新目标和方法.
结论:
- 了解免疫抑制因素对于提高ICI疗效至关重要.
- 针对免疫抑制性瘤微环境提供了增强癌症免疫疗法的有希望的策略.
- 该领域的进一步研究可能会为癌症患者带来更好的临床结果.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520


